Saptagir signs deal with Jubilant Generics to manufacture ‘Remdesivir’
Hyderabad(Hyd): Hyderabad(Hyd)-based Saptagir Laboratories on Mon. declared that it’s signed an exclusive settlement with Jubilant Generics to manufacture intermediates & Active Pharmaceutical Ingredient for intravenous administered drug ‘Remdesivir’ utilized in COVID-19-19 medication. The drug going to be produced in its Hyderabad(Hyd) WHO-GMP certified sterile drug product manufacturing plant acquired in an investment of INR 75 cr. …